Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites

Kolja Paech(University of California, San Francisco), Paul Webb(University of California, San Francisco), George G. J. M. Kuiper(University of California, San Francisco), Stefan Nilsson(University of California, San Francisco), Jan-Ακε Gustafsson(University of California, San Francisco), Peter J. Kushner(University of California, San Francisco), Thomas S. Scanlan(University of California, San Francisco)
Science
September 5, 1997
Cited by 1,854

Abstract

The transactivation properties of the two estrogen receptors, ERalpha and ERbeta, were examined with different ligands in the context of an estrogen response element and an AP1 element. ERalpha and ERbeta were shown to signal in opposite ways when complexed with the natural hormone estradiol from an AP1 site: with ERalpha, 17beta-estradiol activated transcription, whereas with ERbeta, 17beta-estradiol inhibited transcription. Moreover, the antiestrogens tamoxifen, raloxifene, and Imperial Chemical Industries 164384 were potent transcriptional activators with ERbeta at an AP1 site. Thus, the two ERs signal in different ways depending on ligand and response element. This suggests that ERalpha and ERbeta may play different roles in gene regulation.


Related Papers

No related papers found

Powered by citation graph analysis